Chondrocyte Therapeutic Delivery Stystem
First Claim
Patent Images
1. A method for ameliorating a disorder or injury in a subject using a genetically altered chondrocyte, comprising:
- providing a genetically altered chondrocyte, wherein the genetically altered chondrocyte has been altered to express a therapeutic agent;
implanting a biocompatible substrate comprising a genetically altered chondrocyte into a target region of the subject, wherein the genetically altered chondrocyte is not structurally functional in the target region or an environment surrounding the target region; and
expressing the therapeutic agent in the target region at a level sufficient to ameliorate the disorder.
0 Assignments
0 Petitions
Accused Products
Abstract
Methods and compositions for producing therapeutic agents using chondrocytes are provided. The genetically engineered chondrocytes can be used to express the therapeutic agent in a subject, including in an environment typically associated with chondrocytes and in an environment not typically associated with chondrocytes.
-
Citations
12 Claims
-
1. A method for ameliorating a disorder or injury in a subject using a genetically altered chondrocyte, comprising:
-
providing a genetically altered chondrocyte, wherein the genetically altered chondrocyte has been altered to express a therapeutic agent; implanting a biocompatible substrate comprising a genetically altered chondrocyte into a target region of the subject, wherein the genetically altered chondrocyte is not structurally functional in the target region or an environment surrounding the target region; and expressing the therapeutic agent in the target region at a level sufficient to ameliorate the disorder. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)
-
Specification